These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23526671)
1. Genetic association of adrenergic receptor alpha 2A with obesity and type 2 diabetes. Långberg EC; Seed Ahmed M; Efendic S; Gu HF; Östenson CG Obesity (Silver Spring); 2013 Aug; 21(8):1720-5. PubMed ID: 23526671 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the association between the ADRA2A genetic polymorphisms and type 2 diabetes in a Chinese Han population. Li T; Zhu X; Wu X; Li J; Pan L; Li P; Xin Z; Gu HF; Liu Y Genet Test Mol Biomarkers; 2012 Dec; 16(12):1424-7. PubMed ID: 23153004 [TBL] [Abstract][Full Text] [Related]
3. Association of the ADRA2A polymorphisms with the risk of type 2 diabetes: a meta-analysis. Chen X; Liu L; He W; Lu Y; Ma D; Du T; Liu Q; Chen C; Yu X Clin Biochem; 2013 Jun; 46(9):722-6. PubMed ID: 23462695 [TBL] [Abstract][Full Text] [Related]
4. Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals. Bao XY; Peng B; Yang MS Mol Biol Rep; 2012 Mar; 39(3):2447-54. PubMed ID: 21643948 [TBL] [Abstract][Full Text] [Related]
5. Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians. Långberg EC; Gu HF; Nordman S; Efendic S; Ostenson CG Eur J Endocrinol; 2007 Oct; 157(4):459-64. PubMed ID: 17893260 [TBL] [Abstract][Full Text] [Related]
6. Genetic variation of the adenylyl cyclase 3 (AC3) locus and its influence on type 2 diabetes and obesity susceptibility in Swedish men. Nordman S; Abulaiti A; Hilding A; Långberg EC; Humphreys K; Ostenson CG; Efendic S; Gu HF Int J Obes (Lond); 2008 Mar; 32(3):407-12. PubMed ID: 17895882 [TBL] [Abstract][Full Text] [Related]
7. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population. Robiou-du-Pont S; Bonnefond A; Yengo L; Vaillant E; Lobbens S; Durand E; Weill J; Lantieri O; Balkau B; Charpentier G; Marre M; Froguel P; Meyre D Int J Obes (Lond); 2013 Jul; 37(7):980-5. PubMed ID: 23090577 [TBL] [Abstract][Full Text] [Related]
8. Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies. Talmud PJ; Cooper JA; Gaunt T; Holmes MV; Shah S; Palmen J; Drenos F; Shah T; Kumari M; Kivimaki M; Whittaker J; Lawlor DA; Day IN; Hingorani AD; Casas JP; Humphries SE Diabetologia; 2011 Jul; 54(7):1710-9. PubMed ID: 21455730 [TBL] [Abstract][Full Text] [Related]
9. The rs10885122 polymorphism of the adrenoceptor alpha 2A (ADRA2A) gene in Euro-Brazilians with type 2 diabetes mellitus. Welter M; Frigeri HR; Réa RR; de Souza EM; Alberton D; Picheth G; Rego FG Arch Endocrinol Metab; 2015 Feb; 59(1):29-33. PubMed ID: 25926111 [TBL] [Abstract][Full Text] [Related]
10. The ADRA2A rs553668 variant is associated with type 2 diabetes and five variants were associated at nominal significance levels in a population-based case-control study from Mexico City. Totomoch-Serra A; Muñoz ML; Burgueño J; Revilla-Monsalve MC; Perez-Muñoz A; Diaz-Badillo Á Gene; 2018 Aug; 669():28-34. PubMed ID: 29800730 [TBL] [Abstract][Full Text] [Related]
11. Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population: A case-control study. Kong X; Xing X; Hong J; Zhang X; Yang W Medicine (Baltimore); 2016 Jun; 95(23):e3841. PubMed ID: 27281091 [TBL] [Abstract][Full Text] [Related]
12. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. Sanghera DK; Ortega L; Han S; Singh J; Ralhan SK; Wander GS; Mehra NK; Mulvihill JJ; Ferrell RE; Nath SK; Kamboh MI BMC Med Genet; 2008 Jul; 9():59. PubMed ID: 18598350 [TBL] [Abstract][Full Text] [Related]
14. Association study between chromosome 10q26.11 and obesity among Swedish men. Lavebratt C; Sengul S; Gu HF; Persson B; Nordfors L; Ostenson CG; Efendic S; Arner P; Hoffstedt J; Schalling M Int J Obes (Lond); 2005 Dec; 29(12):1422-8. PubMed ID: 15997241 [TBL] [Abstract][Full Text] [Related]
15. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. Cauchi S; Nead KT; Choquet H; Horber F; Potoczna N; Balkau B; Marre M; Charpentier G; Froguel P; Meyre D BMC Med Genet; 2008 May; 9():45. PubMed ID: 18498634 [TBL] [Abstract][Full Text] [Related]
16. A genetic variation in the fat mass- and obesity-associated gene is associated with obesity and newly diagnosed type 2 diabetes in a Chinese population. Li X; Song F; Jiang H; Zhang M; Lin J; Bao W; Yao P; Yang X; Hao L; Liu L Diabetes Metab Res Rev; 2010 Feb; 26(2):128-32. PubMed ID: 20186840 [TBL] [Abstract][Full Text] [Related]
17. A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. Rosmond R; Bouchard C; Björntorp P J Intern Med; 2002 Mar; 251(3):252-7. PubMed ID: 11886485 [TBL] [Abstract][Full Text] [Related]
18. The rs553668 polymorphism of the ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based study. Bo S; Cassader M; Cavallo-Perin P; Durazzo M; Rosato R; Gambino R Diabet Med; 2012 Apr; 29(4):549-52. PubMed ID: 22061269 [TBL] [Abstract][Full Text] [Related]
19. Alpha2A adrenergic receptor genetic variation contributes to hyperglycemia after myocardial infarction. Adefurin A; Vanderbilt C; Okafor C; Kawai V; Li C; Shah A; Wei WQ; Kurnik D; Stein CM Int J Cardiol; 2016 Jul; 215():482-6. PubMed ID: 27131769 [TBL] [Abstract][Full Text] [Related]
20. Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. Perry JR; Voight BF; Yengo L; Amin N; Dupuis J; Ganser M; Grallert H; Navarro P; Li M; Qi L; Steinthorsdottir V; Scott RA; Almgren P; Arking DE; Aulchenko Y; Balkau B; Benediktsson R; Bergman RN; Boerwinkle E; Bonnycastle L; Burtt NP; Campbell H; Charpentier G; Collins FS; Gieger C; Green T; Hadjadj S; Hattersley AT; Herder C; Hofman A; Johnson AD; Kottgen A; Kraft P; Labrune Y; Langenberg C; Manning AK; Mohlke KL; Morris AP; Oostra B; Pankow J; Petersen AK; Pramstaller PP; Prokopenko I; Rathmann W; Rayner W; Roden M; Rudan I; Rybin D; Scott LJ; Sigurdsson G; Sladek R; Thorleifsson G; Thorsteinsdottir U; Tuomilehto J; Uitterlinden AG; Vivequin S; Weedon MN; Wright AF; ; ; ; Hu FB; Illig T; Kao L; Meigs JB; Wilson JF; Stefansson K; van Duijn C; Altschuler D; Morris AD; Boehnke M; McCarthy MI; Froguel P; Palmer CN; Wareham NJ; Groop L; Frayling TM; Cauchi S PLoS Genet; 2012 May; 8(5):e1002741. PubMed ID: 22693455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]